People

Peter Parker

Peter D. Parker is published as a Mission Bay Capital venture partner in its undated directory. The biography describes his historical managing general partner affiliation with BioInnovation Capital, his cofounding of Cambridge BioLabs and LabCentral with Johannes Fruehauf, and earlier life-science investing at Ampersand Capital Partners. He was President and CEO of Cequent Pharmaceuticals from2006to2010 and studied at Columbia University. The undated BioInnovation title is historical context rather than proof of a currently independent adviser; he is distinct from unrelated Peter Parker names.